ascopubs.org

Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression ...

Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study. If you have the ...
ascopubs.org

Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group

Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma To our knowledge, this is the largest study to date to comprehensively evaluate NK-t-AML and provides a framework that ...
BioWorld

Janssen presents first-in-class bispecific Vδ2 T-cell engaging antibody

The lack of acute myeloid leukemia-specific antigens is one of the challenges for targeted immunotherapy together with on-target off-tumor toxicities due to the expression of the target in normal ...
Drug Target Review

Targeting inflammatory cell death to tackle relapse in AML

Discover the challenges of acute myeloid leukaemia linked to inflammatory cell death and the quest for effective therapies.